- Trials with a EudraCT protocol (999)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
999 result(s) found for: E A Ratio.
Displaying page 1 of 50.
EudraCT Number: 2009-011006-42 | Sponsor Protocol Number: vs.3.23-02-2009 | Start Date*: 2009-07-13 | ||||||||||||||||
Sponsor Name:Rigshospitalet, Hjertemedicinsk afd. B | ||||||||||||||||||
Full Title: Sildenafil and diastolic dysfunction after AMI | ||||||||||||||||||
Medical condition: Diastolic dysfunction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002365-35 | Sponsor Protocol Number: GC1008FSGS03110 | Start Date*: 2013-07-15 | |||||||||||
Sponsor Name:Genzyme Corporation | |||||||||||||
Full Title: A Phase 2, Multicenter, Double-Blind, Parallel Dosing, Randomized Study of Fresolimumab or Placebo in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis | |||||||||||||
Medical condition: Focal segmental glomerulosclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002021-35 | Sponsor Protocol Number: ANR-1/14 | Start Date*: 2014-09-23 |
Sponsor Name:Fondazione IRCCS Istituto Nazionale dei Tumori | ||
Full Title: Decurarization After Thoracic Anesthesia - A prospective multicenter double-blind randomized trial comparing sugammadex vs neostigmine reversal after thoracic anesthesia | ||
Medical condition: Neuromuscular block is commonly adopted during general anesthesia to facilitate tracheal intubation, mechanical ventilation and surgical manipulation. At the end of anesthesia it very important to ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002269-21 | Sponsor Protocol Number: 01.00240 | Start Date*: 2013-12-06 |
Sponsor Name:Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto | ||
Full Title: Metformin in diastolic dysfunction of metabolic syndrome | ||
Medical condition: Diastolic dysfunction in non-diabetic patients with metabolic syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: PT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002020-25 | Sponsor Protocol Number: 052017 | Start Date*: 2018-08-31 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: ANGIOTENSIN–NEPRILYSIN INHIBITION IN DIASTOLIC DYSFUNCTION AFTER AMI | |||||||||||||
Medical condition: Diastolic dysfunction after acute myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003827-37 | Sponsor Protocol Number: 20110109 | Start Date*: 2012-01-06 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Long-term Tolerability and Durable Efficacy of AMG 145 on LDL-C in Hyperlipidemic Subjects | |||||||||||||
Medical condition: Hyperlipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) BE (Completed) AT (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001264-11 | Sponsor Protocol Number: UMCM-2016EPI05 | Start Date*: 2016-09-07 |
Sponsor Name:University Medical Center of the Johannes Gutenberg-University Mainz | ||
Full Title: A phase IV, single-center, randomized, double-blind, placebo-controlled, parallel group study on the effects of empagliflozin on left ventricular diastolic function compared to usual care in indivi... | ||
Medical condition: Poorly controlled type 2 diabetes mellitus in adults | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000805-27 | Sponsor Protocol Number: MEIN/10/Ran-Did/001 | Start Date*: 2012-10-23 | |||||||||||
Sponsor Name:Menarini International Operations Luxembourg S.A., Avenue de la Gare, 1611 Luxembourg, Luxembourg | |||||||||||||
Full Title: Effect of Ranolazine in Heart Failure Patients with Preserved Ejection Fraction | |||||||||||||
Medical condition: Heart failure patients with preserved ejection fraction (HFpEF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001812-80 | Sponsor Protocol Number: 11-12-23/03-intern-6470 | Start Date*: 2011-11-25 | |||||||||||
Sponsor Name:Maastro Clinic | |||||||||||||
Full Title: Non invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Head and Neck Cancer. | |||||||||||||
Medical condition: Patients with histological or cytological confirmed squamous cell carcinomas of the oral cavity, oropharynx, hypopharynx, larynx, T2-T3-T4, any N, M0 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2023-000171-13 | Sponsor Protocol Number: P23 | Start Date*: 2023-08-23 | ||||||||||||||||
Sponsor Name:leiden university medical center | ||||||||||||||||||
Full Title: SGM-101 tumor-targeted fluorescence endoscopy to enable discrimination of malignant from benign tissue in rectal polyps with suspected T1 adenocarcinoma or high grade dysplasia: a feasibility study | ||||||||||||||||||
Medical condition: Early rectal cancer/ big polyps with suspected T1 rectal cancer. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003280-26 | Sponsor Protocol Number: IMB101-005 | Start Date*: 2020-11-09 | |||||||||||
Sponsor Name:Imbria Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Dose-Ranging Pharmacodynamic Study to Evaluate the Effects of IMB-1018972 on Myocardial Energetics, Metabolism, and Function in Patients with Type 2 Diabetes | |||||||||||||
Medical condition: Diabetic Cardiomyopathy (DbCM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000540-26 | Sponsor Protocol Number: CVT-CV-002 | Start Date*: 2013-05-12 | |||||||||||
Sponsor Name:CVie Therapeutics Company Limited | |||||||||||||
Full Title: The clinical study of the safety and efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure - A multicenter, randomized, double-blind, placebo controlled, parallel group clinical ... | |||||||||||||
Medical condition: Acute heart failure decompensated | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-005074-19 | Sponsor Protocol Number: BRIDION_ERASME | Start Date*: 2018-04-06 |
Sponsor Name:Erasme Hospital | ||
Full Title: Minimal optimal dose of Sugammadex during ambulatory surgery in dentistry | ||
Medical condition: women and men> 18 years of age Elective Surgery BMI <30, patients who gave consent to free and informed participation in writing to benefit from tooth extraction | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000057-27 | Sponsor Protocol Number: 72544 | Start Date*: 2021-10-27 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Recovery of carotid body function after full recovery neuromuscular block | ||
Medical condition: Postoperative ventilatory control | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012049-46 | Sponsor Protocol Number: IEO S480/209 | Start Date*: 2010-07-29 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA | |||||||||||||
Full Title: Phase III, randomized, double blind trial on Vitamin D supplementation for resected stage II melanoma patients. | |||||||||||||
Medical condition: melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002270-12 | Sponsor Protocol Number: TRIMETA | Start Date*: 2016-10-20 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA | |||||||||||||
Full Title: Clinical trial phase II, prospective, open, randomized, controlled study to evaluate the preventive effect of trimetazidine on the cardiotoxicity of trastuzumab and chemotherapy in patients with br... | |||||||||||||
Medical condition: BREAST CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003020-32 | Sponsor Protocol Number: A011-16 | Start Date*: 2022-02-03 | |||||||||||
Sponsor Name:Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ, USA | |||||||||||||
Full Title: Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo-Controlled for the Treatment of Combined Postcapillary and Precapillary Pulmonary ... | |||||||||||||
Medical condition: Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) DE (Ongoing) ES (Ongoing) IT (Ongoing) SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001550-34 | Sponsor Protocol Number: TIGEM2-PDH | Start Date*: Information not available in EudraCT | |||||||||||||||||||||||||||||||
Sponsor Name:FONDAZIONE TELETHON | |||||||||||||||||||||||||||||||||
Full Title: Studio clinico pilota per valutare l’efficacia della terapia con fenilbutirrato in pazienti affetti da deficit di piruvato deidrogenasi | |||||||||||||||||||||||||||||||||
Medical condition: La Sperimentazione verrà eseguita su pazienti affetti da difetto dell’enzima piruvato deidrogenasi.I pazienti affetti da questa malattia manifestano aumento dei livelli di lattato nel sangue e nell... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005116-41 | Sponsor Protocol Number: AOP0071 | Start Date*: 2015-06-24 |
Sponsor Name:University of Padova | ||
Full Title: Postoperative pulmonary function in patients undergoing laparoscopic sleeve gastrectomy after administration of sugammadex and neostigmine. A double-blind, randomized controlled trial. | ||
Medical condition: Reversal of rocuronium-induced neuromuscular blockade | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003837-13 | Sponsor Protocol Number: ROPPET-NAF | Start Date*: 2020-04-20 |
Sponsor Name:Centro Hospitalar e Universitário de Coimbra, E.P.E. | ||
Full Title: Rosuvastatin effect on atherosclerotic plaque metabolism ¿ a subclinical atherosclerosis imaging study with 18F-NaF PET-CT | ||
Medical condition: Atherosclerosis, namely in the aorta, carotid and coronary arteries | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PT (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.